Your browser doesn't support javascript.
loading
DANFIN functions as an inhibitor of transcription factor NF-κB and potentiates the antitumor effect of bortezomib in multiple myeloma.
Uematsu, Atsushi; Kido, Kohki; Manabe, Erika; Takeda, Hiroyuki; Takahashi, Hirotaka; Hayashi, Minoru; Imai, Yuuki; Sawasaki, Tatsuya.
  • Uematsu A; Division of Cell-Free Sciences, Proteo-Science Center (PROS), Ehime University, Japan.
  • Kido K; Division of Cell-Free Sciences, Proteo-Science Center (PROS), Ehime University, Japan.
  • Manabe E; Division of Cell-Free Sciences, Proteo-Science Center (PROS), Ehime University, Japan.
  • Takeda H; Division of Proteo-Drug-Discovery Sciences, PROS, Ehime University, Japan.
  • Takahashi H; Division of Cell-Free Sciences, Proteo-Science Center (PROS), Ehime University, Japan.
  • Hayashi M; Department of Materials Science and Biotechnology, Graduate School of Science and Engineering, Ehime University, Japan.
  • Imai Y; Division of Integrative Pathophysiology, PROS, Ehime University, Japan.
  • Sawasaki T; Division of Cell-Free Sciences, Proteo-Science Center (PROS), Ehime University, Japan. Electronic address: sawasaki@ehime-u.ac.jp.
Biochem Biophys Res Commun ; 495(3): 2289-2295, 2018 01 15.
Article en En | MEDLINE | ID: mdl-29284118

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / FN-kappa B / Apoptosis / Diaminas / Bortezomib / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / FN-kappa B / Apoptosis / Diaminas / Bortezomib / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Año: 2018 Tipo del documento: Article